Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
- 1Department of Surgery, University of Cambridge, Cambridge, United Kingdom
- 2Department of Paediatric Nephrology, Nottingham University Hospital, Nottingham, United Kingdom
- 3Department of Pediatrics I, University Children’s Hospital Heidelberg, Heidelberg, Germany
- 4School of Medicine, Tulane University, New Orleans, LA, United States
- 5Transplantation Immunology, Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany
- 6Renal Transplant Unit Bambino Gesù, Children’s Hospital, Rome, Italy
- 7University Hospital Hamburg, Pediatric Nephrology, Hamburg, Germany
- 8Clinic for Paediatrics III, Essen University Hospital, Essen, Germany
- 9Pediatric Nephrology, Children’s and Adolescents’ Hospital, University Hospital Cologne, Cologne, Germany
- 10University Hospital Tübingen, Pediatric Nephrology, Tübingen, Germany
- 11Department of General Pediatrics, University Children’s Hospital, Münster, Germany
- 12NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge and the NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom
A Corrigendum on
Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
By Kim JJ, Fichtner A, Copley HC, Gragert L, Süsal C, Dello Strologo L, Oh J, Pape L, Weber LT, Weitz M, König J, Krupka K, Tönshoff B and Kosmoliaptsis V (2023) Front. Immunol. 14:1092335. doi: 10.3389/fimmu.2023.1092335
In the published article, there was an error in the Funding statement. We missed out an extra funder. The correct Funding statement appears below:
The CERTAIN registry received funding from Astellas and Novartis. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. All authors declare no other competing interests. The authors gratefully acknowledge the funding of the CERTAIN Registry by a grant from the Dietmar Hopp Stiftung, the European Society for Paediatric Nephrology (ESPN) and The German Society for Paediatric Nephrology (GPN). JKi acknowledges funding from a MRC NIHR fellowship (MR/V037900/1). CS acknowledges funding from the European Commision’s Horizon 2020 Research and Innovation Programme (grant no. 952512). VK acknowledges funding from an NIHR Fellowship (PDF-2016-09-065) and as a Paul I. Terasaki Scholar.
VK acknowledges funding from the National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU, Grant number: NIHR203332) in Organ Donation and Transplantation at the University of Cambridge in collaboration with Newcastle University and in partnership with NHS Blood and Transplant (NHSBT). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, the Department of Health or National Health Service Blood and Transplant.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: kidney transplantation, HLA mismatch, molecular mismatch, eplets, predictive modeling, antibody mediated rejection (ABMR), donor specific HLA antibodies
Citation: Kim JJ, Fichtner A, Copley HC, Gragert L, Süsal C, Strologo LD, Oh J, Pape L, Weber LT, Weitz M, König J, Krupka K, Tönshoff B and Kosmoliaptsis V (2023) Corrigendum: Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation. Front. Immunol. 14:1188527. doi: 10.3389/fimmu.2023.1188527
Received: 17 March 2023; Accepted: 20 March 2023;
Published: 24 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Kim, Fichtner, Copley, Gragert, Süsal, Strologo, Oh, Pape, Weber, Weitz, König, Krupka, Tönshoff and Kosmoliaptsis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vasilis Kosmoliaptsis, vk256@cam.ac.uk
†Present address: Caner Süsal, Transplant Immunology Research Center of Excellence, Koc University Hospital, Istanbul, Türkiye
‡These authors have contributed equally to this work
§These authors share senior authorship